View Older Stories View More Recent Stories

Apr 18, 2017 09:00AM Aftermaster Partners With Maxim Group LLC For Investment Banking Services
Apr 17, 2017 07:48AM Maxim Group Reiterates Buy Rating and $4 PT on CASI Pharmaceuticals (CASI); Patient Enrollment for Ph2 ENMD-2076 Study is Complete
Apr 13, 2017 02:32PM Maxim Group Maintains Buy Rating and $6 PT on Intellipharmaceutics (IPCI) Following 1Q Results Miss; 'Focused on Rexista Now'
Apr 13, 2017 02:22PM Maxim Group Reiterates Buy Rating and $21 PT on Sucampo Pharmaceuticals (SCMP); 'We See Upside in the Stock'
Apr 12, 2017 12:30PM Maxim Group Upgrades TrovaGene (TROV) to Buy
Apr 12, 2017 11:58AM TICC Capital Corp. Completes Public Offering of $64,370,225 6.50% Notes Due 2024
Apr 12, 2017 11:49AM Virtual Health Partners Closes Series A Financing
Apr 12, 2017 08:38AM PlacementTracker Publishes Q1 2017 Private Placement Market League Tables
Apr 11, 2017 08:46AM Cytori Therapeutics (CYTX) Prices 8.6M Common Stock Offering at $1.10/Share
Apr 11, 2017 08:45AM Cytori Announces Pricing of $9.5M Public Offering of Common Stock
Apr 11, 2017 07:00AM OneSoft Subsidiary, OneBridge Solutions Inc., Presents at Banff 2017 Pipeline Workshop; OneSoft Presents at Microcap Investors Conference in New York City
Apr 11, 2017 06:26AM Naked Brand (NAKD) Raises $5.5M from ATM Program; Amends LOI with Bendon
Apr 11, 2017 06:15AM Naked Brand Group Announces $5.5 Million in Gross Proceeds from Completed At The Market Offering; Amends LOI with Bendon to Reflect $34 Million in Expected Balance Sheet Improvements
Apr 10, 2017 04:02PM Cytori Therapeutics (CYTX) to Offer Common Stock via Maxim Group
Apr 10, 2017 04:01PM Cytori Announces Proposed Public Offering of Common Stock
Apr 10, 2017 02:13PM Maxim Group Reiterates Buy Rating and $14 PT on Abeona Therapeutics (ABEO) Ahead of ABO-102 Incremental Data Presentation on 4/11
Apr 10, 2017 11:20AM Maxim Group Reiterates Buy Rating and $6 PT on Intellipharmceutics (IPCI) Following Lawsuit from Purdue Pharma Over Rexista
Apr 10, 2017 07:40AM Maxim Group Reiterates Buy Rating and $14 PT on Mesoblast Limited (MESO); 'Successful Interim Analysis of Efficacy Endpoint in Pivotal Heart Failure Trial'
Apr 6, 2017 07:52AM Maxim Group Downgrades Fifth Street Senior (FSFR) to Hold
Apr 5, 2017 11:22AM BioLineRx Closes $28.75 Million Underwritten Public Offering of its American Depositary Shares
Apr 4, 2017 05:28PM TICC Capital Corp. Prices Public Offering of $57.5 Million 6.50% Notes Due 2024
Apr 4, 2017 09:00AM New Age Beverages Corporation Announces Investor Conference Call to Discuss 2016 Results
Apr 4, 2017 03:01AM Versus Systems to Present at the MicroCap Conference in New York City at the Essex House
Apr 3, 2017 04:23PM TICC Capital Corp. Announces Offering of Notes
Apr 3, 2017 04:05PM Seanergy Maritime Holdings Corp. Reports Financial Results for the Fourth Quarter and Twelve Months Ended December 31, 2016
Apr 3, 2017 03:20PM Sucampo Pharmaceuticals (SCMP) PT Raised to $21 at Maxim Group; Vtesse 'Could Be a Great Deal'
Apr 3, 2017 07:39AM Kite Pharma (KITE) PT Raised to $100 at Maxim Group
Mar 31, 2017 06:13PM First Capital Real Estate Trust Incorporated And PhotoMedex, Inc. Announce Entry Into Contribution Agreement
Mar 31, 2017 08:27AM BioLineRx (BLRX) Prices 29.4M Offering at $0.85/ADS
Mar 31, 2017 08:25AM BioLineRx Prices $25 Million Underwritten Public Offering
Mar 31, 2017 08:04AM Cytosorbents (CTSO) Prices 2.22M Share Follow-On Offering at $4.50
Mar 31, 2017 08:00AM CytoSorbents Announces Pricing of Follow-On Offering
Mar 31, 2017 07:46AM Maxim Group Reiterates Buy Rating and $14 PT on Mesoblast Limited (MESO); 'Locking the Database Up for Interim Analysis'
Mar 31, 2017 07:33AM Maxim Group Upgrades Vertex (VRTX) to Buy
Mar 30, 2017 10:49AM Maxim Group Reiterates Buy Rating and $11 PT on Intec Phara (NTEC); 'Ph3 Accordian Study Unfolding as Planned'
Mar 30, 2017 10:44AM Maxim Group Reiterates Buy Rating and $22 PT on Omeros (OMER) Following Positive OMS721 Phase 2 Trial Data
Mar 30, 2017 10:34AM Maxim Group Reiterates Buy Rating and $11 PT on AEterna Zentaris (AEZS) Following News of Macrilen NDA in 3Q17
Mar 30, 2017 09:33AM Brainstorm Cell Therapeutics (BCLI) PT Raised to $8 at Maxim Group
Mar 29, 2017 10:31AM Maxim Group Downgrades Ritter Pharmaceuticals (RTTR) to Hold
Mar 28, 2017 12:11PM Maxim Group Reiterates Buy Rating and $22 PT on Omeros (OMER) Following OMS721 Positive Case Report
Mar 28, 2017 08:30AM First Choice Healthcare Solutions to Present at the Microcap Conference on April 4, 2017 in New York City
Mar 28, 2017 07:49AM Maxim Group Reiterates Buy and $32 PT on Zynerba Pharma (ZYNE) Following 4Q Results; 'P2 POC Data in Epilepsy Approaching in 3Q17'
Mar 28, 2017 07:29AM Maxim Group Starts VistaGen Therapeutics (VTGN) at Buy
Mar 24, 2017 07:58AM Maxim Group Reiterates Hold Rating on NovaBay Pharma (NBY) Following 4Q Results
Mar 24, 2017 07:42AM Maxim Group Maintain Buy Rating and $9 PT on Galmed Pharma (GLMD) Following Q4 EPS Miss; 'Lack of N-T Catalysts'
Mar 24, 2017 07:35AM Maxim Group Reiterates Buy Rating and $9 PT on Intec Pharma (NTEC) Following Ph1 Trial Initiation of CBD/THC Using the Accordion Delivery System
Mar 23, 2017 09:02AM Interpace Diagnostics (IDXG) Enters Agreement to Restructure Debt and Terminate Royalty and Milestone Obligations
Mar 23, 2017 09:00AM Interpace Diagnostics Group Announces Agreements to Successfully Restructure Debt and Terminate Royalty and Milestone Obligations
Mar 23, 2017 08:14AM Maxim Group Downgrades Nimble Storage (NMBL) to Hold Following Deal With Hewlett Packard Enterprise (HPE)
Mar 23, 2017 07:59AM Maxim Group Reiterates Buy Rating and $10 PT on Cytosorbents (CTSO) Following Dr. Carl June's Election to the Advisory Board
View More Recent Stories View Older Stories